The previous hypothesis enunciated suggested the fact that leptin/ghrelin ratio can be used to identify subjects with an unfavorable evolution after obesity weight-loss therapeutic treatment [54,79], with weight regain after successful weight loss [54]. The gene discussed is GHRL; the disease is obesity due to melanocortin 4 receptor deficiency.